Literature DB >> 14105221

METABOLISM OF BENCE JONES PROTEINS.

A SOLOMON, T A WALDMANN, J L FAHEY, A S MCFARLANE.   

Abstract

Keywords:  BENCE JONES PROTEIN; ELECTROPHORESIS; IODINE ISOTOPES; PROTEIN METABOLISM; PROTEIN-BOUND IODINE TEST; PROTEINURIA; UREA; URINE

Mesh：

Substances：

Year:  1964        PMID： 14105221      PMCID： PMC289501          DOI： 10.1172/JCI104884

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  34 in total

1.  Further studies of the gamma-related proteins of normal urine.

Authors:  G T STEVENSON
Journal:  J Clin Invest       Date:  1962-05       Impact factor: 14.808

2.  The turnover and distribution of I-131-labeled myeloma and macroglobulin proteins.

Authors:  T G GABUZDA
Journal:  J Lab Clin Med       Date:  1962-01

3.  Formation of Bence-Jones protein and myeloma protein in vitro by the plasma-cell tumour MPC-2.

Authors:  B A ASKONAS; J L FAHEY
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

4.  Phagocytosis of heat-denatured human serum albumin labelled with 131I and its use as a means of investigating liver blood flow.

Authors:  B BENACERRAF; G BIOZZI; B N HALPERN; C STIFFEL; D MOUTON
Journal:  Br J Exp Pathol       Date:  1957-02

5.  Aberrations of protein metabolism in multiple myeloma; interrelationships of abnormal serum globulins and Bence-Jones proteins.

Authors:  F W PUTNAM
Journal:  Physiol Rev       Date:  1957-10       Impact factor: 37.312

6.  Site of catabolism of serum albumin.

Authors:  D GITLIN; J R KLINENBERG; W L HUGHES
Journal:  Nature       Date:  1958-04-12       Impact factor: 49.962

7.  The mechanism and significance of protein excretion by the normal kidney.

Authors:  A L SELLERS
Journal:  AMA Arch Intern Med       Date:  1956-12

8.  THE METABOLISM OF NORMAL PLASMA PROTEINS AND GAMMA-MYELOMA PROTEIN IN MICE BEARING PLASMA-CELL TUMORS.

Authors:  J H Humphrey; J L Fahey
Journal:  J Clin Invest       Date:  1961-09       Impact factor: 14.808

9.  Enzymatically produced subunits of proteins formed by plasma cells in mice. II. beta2a-Myeloma protein and Bence Jones protein.

Authors:  B A ASKONAS; J L FAHEY
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

10.  The nature and rates of excretion of radioactive breakdown products of I131-albumin in the rabbit.

Authors:  F ZIZZA; T J CAMPBELL; E B REEVE
Journal:  J Gen Physiol       Date:  1959-11       Impact factor: 4.086
View more
  30 in total

1.  Renal clearance of quantum dots.

Authors:  Hak Soo Choi; Wenhao Liu; Preeti Misra; Eiichi Tanaka; John P Zimmer; Binil Itty Ipe; Moungi G Bawendi; John V Frangioni
Journal:  Nat Biotechnol       Date:  2007-09-23       Impact factor: 54.908

Review 2.  Serum free light chain assessment in monoclonal gammopathy and kidney disease.

Authors:  Colin A Hutchison; Kolitha Basnayake; Paul Cockwell
Journal:  Nat Rev Nephrol       Date:  2009-09-29       Impact factor: 28.314

3.  Urine free light chains in SLE: clonal markers of B-cell activity and potential link to in vivo secreted Ig.

Authors:  J E Hopper; J Golbus; C Meyer; G A Ferrer
Journal:  J Clin Immunol       Date:  2000-03       Impact factor: 8.317

4.  An overview of monoclonal gammapathies.

Authors:  T Malati
Journal:  Indian J Clin Biochem       Date:  2001-01

5.  Incomplete Refolding of Antibody Light Chains to Non-Native, Protease-Sensitive Conformations Leads to Aggregation: A Mechanism of Amyloidogenesis in Patients?

Authors:  Gareth J Morgan; Grace A Usher; Jeffery W Kelly
Journal:  Biochemistry       Date:  2017-12-04       Impact factor: 3.162

6.  [Myeloma-kidney. II. Correlation of structure and function with special reference to acute renal failure (author's transl)].

Authors:  G E Schubert
Journal:  Klin Wochenschr       Date:  1974-08-15

7.  Secretory gamma-A in normal urine.

Authors:  J Bienenstock; T B Tomasi
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

8.  The Kinetic Stability of a Full-Length Antibody Light Chain Dimer Determines whether Endoproteolysis Can Release Amyloidogenic Variable Domains.

Authors:  Gareth J Morgan; Jeffery W Kelly
Journal:  J Mol Biol       Date:  2016-08-26       Impact factor: 5.469

9.  Human myeloma IgG half-molecules. Catabolism and biological properties.

Authors:  H L Spiegelberg
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

10.  The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia.

Authors:  T A Waldmann; W Strober; R P Mogielnicki
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.